Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about KETAMINE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | KETAMINE |
| Key Genes/Proteins | BDNF, CREB, CSF1R, ERK |
| Related Diseases | ANXIETY, BBB, BIPOLAR DISORDER, BLOOD-BRAIN BARRIER, DEPRESSION |
graph TD
KETAMINE["KETAMINE"]
KETAMINE -->|"treats"| Depression["Depression"]
KETAMINE -->|"treats"| rapid_antidepressant_response["rapid antidepressant response"]
KETAMINE -->|"inhibits"| NMDAR["NMDAR"]
KETAMINE -->|"upregulates"| BDNF["BDNF"]
KETAMINE -->|"activates"| ERK["ERK"]
KETAMINE -->|"treats"| acute_kidney_injury["acute kidney injury"]
KETAMINE -->|"targets"| GABAergic_Interneurons["GABAergic Interneurons"]
KETAMINE -->|"treats"| Treatment_Resistant_Depression["Treatment-Resistant Depression"]
BDNF -->|"mediates"| KETAMINE
CSF1R["CSF1R"] -->|"inhibits"| KETAMINE| Target | Relation | Type | Str |
|---|---|---|---|
| Depression | treats | disease | 0.95 |
| depression | treats | disease | 0.90 |
| NMDAR | inhibits | receptor | 0.90 |
| BDNF | upregulates | protein | 0.90 |
| rapid antidepressant response | treats | phenotype | 0.90 |
| hyperarousal | inhibits | phenotype | 0.85 |
| Post-Traumatic Stress Disorder | treats | disease | 0.85 |
| acute kidney injury | treats | disease | 0.85 |
| ERK | activates | protein | 0.85 |
| Neuroplasticity | associated_with | process | 0.85 |
| Treatment-Resistant Depression | treats | disease | 0.85 |
| GABAergic Interneurons | targets | cell_type | 0.85 |
| NPY | upregulates | gene | 0.80 |
| HCN1 | downregulates | gene | 0.80 |
| anxiety | treats | disease | 0.70 |
| BDNF | regulates | gene | 0.70 |
| CA1 | activates | brain_region | 0.70 |
| c-Fos | activates | gene | 0.70 |
| BDNF | associated_with | gene | 0.70 |
| unfolded protein response | modulates | pathway | 0.70 |
| GPR109A | treats | gene | 0.70 |
| BDNF | activates | protein | 0.68 |
| BDNF | interacts_with | gene | 0.65 |
| DEPRESSION | causes | disease | 0.65 |
| DEPRESSION | activates | disease | 0.65 |
| ANXIETY | interacts_with | disease | 0.65 |
| ANXIETY | targets | disease | 0.65 |
| GLUTAMATE | activates | phenotype | 0.65 |
| CA1 | regulates | brain_region | 0.65 |
| BDNF | regulates | gene | 0.65 |
| ANTIDEPRESSANT | associated_with | drug | 0.64 |
| CREB | inhibits | gene | 0.60 |
| DNA | inhibits | gene | 0.60 |
| RNA | inhibits | gene | 0.60 |
| CREB | regulates | gene | 0.60 |
| ERK | regulates | gene | 0.60 |
| CREB | activates | gene | 0.60 |
| CREB | associated_with | gene | 0.60 |
| ERK | associated_with | gene | 0.60 |
| PTSD | treats | disease | 0.60 |
| HCN1 | activates | gene | 0.60 |
| HCN1 | expressed_in | gene | 0.60 |
| HCN1 | regulates | gene | 0.60 |
| HCN1 | implicated_in | gene | 0.60 |
| GPR109A | implicated_in | gene | 0.60 |
| GPR109A | biomarker_for | gene | 0.60 |
| GPR109A | expressed_in | gene | 0.60 |
| schizophrenia | treats | disease | 0.60 |
| BDNF | interacts_with | gene | 0.60 |
| DEPRESSION | stabilizes | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| BDNF | mediates | protein | 0.88 |
| CSF1R | inhibits | gene | 0.65 |
| BDNF | inhibits | gene | 0.65 |
| BDNF | stabilizes | gene | 0.60 |
| INFLAMMATION | associated_with | phenotype | 0.45 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| GLUTAMATE | associated_with | phenotype | 0.45 |
| DEPRESSION | associated_with | disease | 0.45 |
| BDNF | associated_with | gene | 0.45 |
| ANXIETY | associated_with | disease | 0.45 |
| CREB | associated_with | gene | 0.45 |
| ERK | associated_with | gene | 0.45 |
| CSF1R | associated_with | gene | 0.45 |
| BLOOD-BRAIN BARRIER | associated_with | phenotype | 0.45 |
| BBB | associated_with | phenotype | 0.45 |
| FLUOXETINE | associated_with | drug | 0.45 |
| BIPOLAR DISORDER | associated_with | disease | 0.45 |
| MICROGLIA | associated_with | cell_type | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning KETAMINE in their description or question text
No additional research found